Tumour-infiltrating FOXP3+ lymphocytes are associated with cytotoxic immune responses and good clinical outcome in oestrogen receptor-negative breast cancer
2012 · British Journal of Cancer · 257 citations
https://doi.org/10.1038/bjc.2012.524
K
Katy Milne
BC Cancer Agency(CA)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
270
Papers
7.6K
Citations
37
h-index
56
i10-index
Katy Milne is an academic researcher from BC Cancer Agency. The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & Immune Cell Function and Interaction & Immune cells in cancer. The author has an h-index of 37, co-authored 230 publications.
ORCID: 0000-0001-5616-1821Papers by this author
worksCD74 and intratumoral immune response in breast cancer
2016 · Oncotarget · 208 citations
https://doi.org/10.18632/oncotarget.8610
The chimeric TAC receptor co-opts the T cell receptor yielding robust anti-tumor activity without toxicity
2018 · Nature Communications · 120 citations
https://doi.org/10.1038/s41467-018-05395-y
Epithelial tumor suppressor ELF3 is a lineage-specific amplified oncogene in lung adenocarcinoma
2019 · Nature Communications · 70 citations
https://doi.org/10.1038/s41467-019-13295-y
Spontaneous Mammary Tumors Differ Widely in Their Inherent Sensitivity to Adoptively Transferred T Cells
2007 · Cancer Research · 33 citations
https://doi.org/10.1158/0008-5472.can-07-0622
Loss of Parkinson’s susceptibility gene LRRK2 promotes carcinogen-induced lung tumorigenesis
2021 · Scientific Reports · 32 citations
https://doi.org/10.1038/s41598-021-81639-0
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat